Psychedelic medicine pipeline
Psychedelic medicine pipeline from mushroom brands, with prices from the local retailers that carry them.
Browse all 59 products
59 products from 27 makers
BPL-003 – Mebufotenin benzoate (5-MeO-DMT) nasal sprayAtaiBeckley
CLA-PSY-201 – Synthetic psilocybin (25 mg)Clairvoyant Therapeutics
Code not specified – M1/M4 muscarinic receptor agonistGilgamesh Pharma
CYB003 – Deuterated psilocin analogCybin Inc.
CYB004 – Deuterated N,N-dimethyltryptamine (DMT)Cybin Inc.
DLX-001 – ZalsupindoleDelix Therapeutics
EB-003 – Novel neuroplastogen designed to engage 5-HT2A and 5-HT1B receptorsEnveric Biosciences
EMP-01 – Oral R-MDMAAtaiBeckley
EVM401 – Novel phenylalkylamine and indolethylamine seriesEnveric Biosciences
FREE-001 – Ketamine + temsirolimusFreedom Biosciences
FREE-002 – KetamineFreedom Biosciences
GM-1020 – BlixeprodilGilgamesh Pharma
GM-2505 – BretisilocinGilgamesh Pharma
GM-3009 – Ibogaine analogGilgamesh Pharma
GM-5022 (code unconfirmed) – Non-hallucinogenic neuroplastogenGilgamesh Pharma
JOUR-5700 – Synthetic mescaline hydrochlorideJourney Colab
LPH-48 – Short-duration 5-HT2A agonist fast-followerLophora ApS
LPH-5 – Selective small-molecule 5-HT2A agonistLophora ApS
MDMA + citalopram – MDMA and citalopram combinationTactogen, Inc.
MDMA – MDMAOptimi Health Corp.
Midomafetamine (MDMA) – MDMALykos Therapeutics (Resilient Pharmaceuticals)
MM120 ODT – Lysergide D-tartrate (LSD)Definium Therapeutics (formerly MindMed)
MM402 – R(-)-MDMADefinium Therapeutics (formerly MindMed)
MSP-1014 – Psilocybin prodrugMindset Pharma
MSP-2003 – Psilocybin-based backup candidateMindset Pharma
MSP-2020 – Psilocybin-based 5-HT2A agonistMindset Pharma
MYCO-001 – Psilocybin from natural fungal sourcesNoveris Health Sciences (formerly Mydecine)
MYCO-002 – Entactogenic compoundNoveris Health Sciences (formerly Mydecine)
MYCO-003 – Psilocybin-based formulationNoveris Health Sciences (formerly Mydecine)
MYCO-004 – Transdermal tryptamine compoundNoveris Health Sciences (formerly Mydecine)
Natural psilocybin 5 mg – Naturally derived psilocybinOptimi Health Corp.
Not reported – Naturally derived psilocybin extractNuminus Wellness Inc.
Not reported – Synthetic psilocybinCeruvia Lifesciences
Not stated – 5-MeO-DMTUsona Institute
Novel 5-HT2A/2C receptor agonists – Novel receptor agonists, including non-hallucinogenic neuroplastogensAtaiBeckley
NPX-5 – Botanical psilocybinPsyence BioMed
NYPRG-101 (BOL-148) – Non-hallucinogenic LSD analogCeruvia Lifesciences
PEX010 – Botanical psilocybinFilament Health
PSIL-001 – Novel neuroplastogenPsilera, Inc.
PSIL-002 – Novel neuroplastogenPsilera, Inc.
PSIL-006 – Non-hallucinogenic psilocybin derivative / neuroplastogenPsilera, Inc.
PSIL-020 – Novel neuroplastogenPsilera, Inc.
PSIL-025 – Novel neuroplastogenPsilera, Inc.
PSIL301 (uAspire; NCT06308653) – PsilocybinUsona Institute
PSX-001 – Synthetic psilocybinIncannex Healthcare Inc.
RE104 (luvesilocin) – 4-OH-DiPT prodrugReunion Neuroscience, Inc.
SP-26 – KetamineSilo Pharma, Inc.
SPT-348 (Glyph2BLSD) – Glyph 2-bromo-LSD, an oral prodrug of 2-bromo-LSDSeaport Therapeutics
SYNP-101 – Synthetic psilocybinCeruvia Lifesciences
SYNP-101 – Synthetic psilocybinB.More Inc
SYNP-102 – PsilocybinB.More Inc
TACT-908 (2ZEDMA) – Benzofuran-based 5-HT1B/5-HT2A agonistTactogen, Inc.
TACT411/833 – Novel entactogenTactogen, Inc.
TRP-8802 – Synthetic oral psilocybinEntropy Neurodynamics
TRP-8803 – IV-infused psilocinEntropy Neurodynamics
UCSF-sponsored study – PsilocybinSilo Pharma, Inc.
Uncoded (NYU/NIDA collaborative study) – PsilocybinB.More Inc
Undisclosed – IbogainePsyence BioMed
VLS-01 – DMT buccal filmAtaiBeckley
Nothing matches yet. Try another name or maker.